STRATA Skin Sciences (SSKN) Cash & Equivalents (2016 - 2025)
STRATA Skin Sciences' Cash & Equivalents history spans 15 years, with the latest figure at $7.9 million for Q4 2025.
- On a quarterly basis, Cash & Equivalents rose 8.97% to $7.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $7.9 million, a 8.97% increase, with the full-year FY2025 number at $7.9 million, up 8.97% from a year prior.
- Cash & Equivalents hit $7.9 million in Q4 2025 for STRATA Skin Sciences, up from $7.1 million in the prior quarter.
- Over the last five years, Cash & Equivalents for SSKN hit a ceiling of $13.0 million in Q3 2021 and a floor of $2.8 million in Q1 2023.
- Historically, Cash & Equivalents has averaged $7.9 million across 5 years, with a median of $7.2 million in 2023.
- Biggest five-year swings in Cash & Equivalents: plummeted 74.14% in 2023 and later surged 85.38% in 2024.
- Tracing SSKN's Cash & Equivalents over 5 years: stood at $12.6 million in 2021, then tumbled by 56.83% to $5.4 million in 2022, then increased by 24.84% to $6.8 million in 2023, then increased by 7.03% to $7.3 million in 2024, then grew by 8.97% to $7.9 million in 2025.
- Business Quant data shows Cash & Equivalents for SSKN at $7.9 million in Q4 2025, $7.1 million in Q3 2025, and $6.0 million in Q2 2025.